First wave of ASH 2026 abstracts released, featuring data from J&J, Servier and AstraZeneca
read at Endpoints ↗Neutral
The American Society of Hematology’s annual meeting is set for New Orleans, Louisiana, a little over a month away.
The first batch of abstracts for the conference has been posted, showcasing early data from companies such as Johnson & Johnson, Servier and AstraZeneca.
The submissions include studies on acute myeloid leukemia and chronic lymphocytic leukemia, with some showing encouraging signals while others report less favorable outcomes.
Endpoints News will attend the meeting in person and will provide ongoing coverage as the data are presented.
source
This writeup was produced by pharmadog from original reporting by Endpoints.
Original headline: “First wave of #ASH26 abstracts is here, with data from J&J, Servier and AstraZeneca”
read at Endpoints ↗90 words · retrieved 34m ago
comments(0)
5-min edit window · permanent after that